Isocitrate dehydrogenase (IDH) mutations, chromosome arm 1p and 19q (1p/19q) codeletion, and O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation are homogeneously present in gliomas (3). This evidence concerns the gene MGMT and central nervous system cancer.